Trade MRNA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Moderna, Inc. (MRNA) is trading at US$154.04, down 2.55% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$57.94B. Over the past 52 weeks, MRNA has traded between US$22.28 and US$176.66. On Syfe you can trade MRNA with $0 commission and add it to your watchlist.
| Previous close | US$158.07 |
|---|---|
| Market cap | US$57.94B |
| 52-week range | US$22.28 – US$176.66 |
| Volume | 20.21M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Moderna, Inc.
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Year: 2018
Moderna, Inc. (MRNA) stock is trading at US$154.04, -2.55% from the previous close of US$158.07.
The market cap for Moderna, Inc. (MRNA) stock is approximately US$57.94B.
The 52-week high for Moderna, Inc. (MRNA) stock is US$176.66.
The 52-week low for Moderna, Inc. (MRNA) stock is US$22.28.
Moderna, Inc. (MRNA) does not currently pay a dividend.
Stay on top of MRNA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
